EDIT:NASDAQ
Editas Medicine Inc
$2.56
arrow_downward
-0.97%(-0.025) 1D
Oct 21, 11:46:15 AM GMT-4 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for EDIT...
Open
$2.59
High
$2.60
Low
$2.54
Mkt. cap
392.40M
Avg. vol.
3.03M
Volume
339.43K
52-wk high
$3.94
52-wk low
$1.66
EPS
-$0.74
Beta
2.00
Shares outstanding
153.58M
No. of employees
87
Open
$2.59
High
$2.60
Low
$2.54
Mkt. cap
392.40M
Avg. vol.
3.03M
Volume
339.43K
52-wk high
$3.94
52-wk low
$1.66
EPS
-$0.74
Beta
2.00
Shares outstanding
153.58M
No. of employees
87
News stories
From web sources and news partners
AD HOC NEWS
·
21 hours ago
Wells Fargo raises target for Editas Medicine stock from USD 4.00 to USD 6.00
Profile
Editas Medicine, Inc., is a clinical-stage biotechnology company which is developing therapies for rare diseases based on CRISPR gene editing technology. Editas headquarters is located in Cambridge, Massachusetts and has facilities in Boulder, Colorado. Wikipedia
About Editas Medicine Inc